241 related articles for article (PubMed ID: 25440792)
1. APPOSITION V: STENTYS coronary stent system clinical trial in subjects with ST-segment elevation myocardial infarction--rationale and design.
Grundeken MJ; Lu H; Mehran R; Cutlip DE; Leon MB; Yeung A; Koch KT; Montalescot G; van Geuns RJ; Spaargaren R; Buchbinder M
Am Heart J; 2014 Nov; 168(5):652-60. PubMed ID: 25440792
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the safety and performance of the STENTYS self-expanding coronary stent in acute myocardial infarction: results from the APPOSITION I study.
Amoroso G; van Geuns RJ; Spaulding C; Manzo-Silberman S; Hauptmann KE; Spaargaren R; García-García HM; Serruys PW; Verheye S
EuroIntervention; 2011 Aug; 7(4):428-36. PubMed ID: 21764660
[TBL] [Abstract][Full Text] [Related]
3. Self-expanding versus balloon-expandable stents in acute myocardial infarction: results from the APPOSITION II study: self-expanding stents in ST-segment elevation myocardial infarction.
van Geuns RJ; Tamburino C; Fajadet J; Vrolix M; Witzenbichler B; Eeckhout E; Spaulding C; Reczuch K; La Manna A; Spaargaren R; García-García HM; Regar E; Capodanno D; Van Langenhove G; Verheye S
JACC Cardiovasc Interv; 2012 Dec; 5(12):1209-19. PubMed ID: 23257368
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry.
Lu H; Grundeken MJ; Vos NS; IJsselmuiden AJJ; van Geuns RJ; Wessely R; Dengler T; La Manna A; Silvain J; Montalescot G; Spaargaren R; Tijssen JGP; Amoroso G; de Winter RJ; Koch KT
EuroIntervention; 2017 Aug; 13(5):e572-e577. PubMed ID: 28191875
[TBL] [Abstract][Full Text] [Related]
5. STENTYS Self-Apposing sirolimus-eluting stent in ST-segment elevation myocardial infarction: results from the randomised APPOSITION IV trial.
van Geuns RJ; Yetgin T; La Manna A; Tamburino C; Souteyrand G; Motreff P; Koch KT; Vrolix M; IJsselmuiden A; Amoroso G; Berland J; Montalescot G; Teiger E; Christiansen EH; Spaargaren R; Wijns W
EuroIntervention; 2016 Feb; 11(11):e1267-74. PubMed ID: 26865444
[TBL] [Abstract][Full Text] [Related]
6. One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study.
Grundeken MJ; Lu H; Vos N; IJsselmuiden A; van Geuns RJ; Wessely R; Dengler T; La Manna A; Silvain J; Montalescot G; Spaargaren R; Tijssen JGP; de Winter RJ; Wykrzykowska JJ; Amoroso G; Koch KT
J Invasive Cardiol; 2017 Aug; 29(8):253-258. PubMed ID: 28756418
[TBL] [Abstract][Full Text] [Related]
7. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.
Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR
J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057
[TBL] [Abstract][Full Text] [Related]
8. Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study.
Nakatani S; Onuma Y; Ishibashi Y; Karanasos A; Regar E; Garcia-Garcia HM; Tamburino C; Fajadet J; Vrolix M; Witzenbichler B; Eeckhout E; Spaulding C; Reczuch K; La Manna A; Spaargaren R; Capodanno D; Van Langenhove G; Verheye S; Serruys PW; van Geuns RJ
EuroIntervention; 2015 Dec; 11(8):885-94. PubMed ID: 26549374
[TBL] [Abstract][Full Text] [Related]
9. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
[TBL] [Abstract][Full Text] [Related]
10. One-year clinical outcomes of the STENTYS Self-Apposing¨ coronary stent in patients presenting with ST-segment elevation myocardial infarction: results from the APPOSITION III registry.
Koch KT; Grundeken MJ; Vos NS; IJsselmuiden AJ; van Geuns RJ; Wessely R; Dengler T; La Manna A; Silvain J; Montalescot G; Spaargaren R; Tijssen JG; Amoroso G
EuroIntervention; 2015 Jul; 11(3):264-71. PubMed ID: 25692610
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the MGuard for acute ST elevation reperfusion MASTER trial.
Costa JR; Abizaid A; Dudek D; Silber S; Leon MB; Stone GW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):184-90. PubMed ID: 23008177
[TBL] [Abstract][Full Text] [Related]
12. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
[TBL] [Abstract][Full Text] [Related]
13. Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial.
Dudek D; Dziewierz A; Brener SJ; Abizaid A; Merkely B; Costa RA; Bar E; Rakowski T; Kornowski R; Dressler O; Abizaid A; Silber S; Stone GW
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001484. PubMed ID: 25603802
[TBL] [Abstract][Full Text] [Related]
14. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study.
Guagliumi G; Sirbu V; Bezerra H; Biondi-Zoccai G; Fiocca L; Musumeci G; Matiashvili A; Lortkipanidze N; Tahara S; Valsecchi O; Costa M
JACC Cardiovasc Interv; 2010 Jun; 3(6):680-7. PubMed ID: 20630463
[TBL] [Abstract][Full Text] [Related]
15. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
Sabaté M; Brugaletta S; Cequier A; Iñiguez A; Serra A; Hernádez-Antolín R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vázquez N; Backx B; Serruys PW
JACC Cardiovasc Interv; 2014 Jan; 7(1):64-71. PubMed ID: 24332423
[TBL] [Abstract][Full Text] [Related]
16. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
[TBL] [Abstract][Full Text] [Related]
17. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.
Di Lorenzo E; Sauro R; Varricchio A; Carbone G; Cortese G; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G
Circulation; 2009 Sep; 120(11):964-72. PubMed ID: 19720939
[TBL] [Abstract][Full Text] [Related]
18. Increased rate of stent thrombosis and target lesion revascularization after filter protection in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: 15-month follow-up of the DEDICATION (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction) trial.
Kaltoft A; Kelbaek H; Kløvgaard L; Terkelsen CJ; Clemmensen P; Helqvist S; Lassen JF; Thuesen L
J Am Coll Cardiol; 2010 Mar; 55(9):867-71. PubMed ID: 20185036
[TBL] [Abstract][Full Text] [Related]
19. Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION).
Chechi T; Vittori G; Biondi Zoccai GG; Vecchio S; Falchetti E; Spaziani G; Baldereschi G; Giglioli C; Valente S; Margheri M
J Interv Cardiol; 2007 Aug; 20(4):282-91. PubMed ID: 17680858
[TBL] [Abstract][Full Text] [Related]
20. Optical Coherence Tomography-Guided Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Prospective Propensity-Matched Cohort of the Thrombectomy Versus Percutaneous Coronary Intervention Alone Trial.
Sheth TN; Kajander OA; Lavi S; Bhindi R; Cantor WJ; Cheema AN; Stankovic G; Niemelä K; Natarajan MK; Shestakovska O; Tittarelli R; Meeks B; Jolly SS
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003414. PubMed ID: 27056766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
